XML 36 R16.htm IDEA: XBRL DOCUMENT
v3.25.1

RESTRUCTURING AND OTHER COSTS | 3 Months Ended
--- | ---
Mar. 31, 2025
Restructuring and Related Activities [Abstract] |
RESTRUCTURING AND OTHER COSTS | RESTRUCTURING AND OTHER COSTS Restructuring and other costs were recorded in the Consolidated Statements of Operations as follows:
|  | Three Months Ended March 31, |  |
(in millions) |  | 2025 |  | 2024 |  |  |  |
Cost of products sold |  | $ | — |  |  | $ | — |  |  |  |  |
Selling, general, and administrative expenses |  | 1 |  |  | 3 |  |  |  |  |
Restructuring and other costs |  | 9 |  |  | 1 |  |  |  |  |
Total restructuring and other costs |  | $ | 10 |  |  | $ | 4 |  |  |  |  |
Restructuring and other costs of $9 million recorded in the first three months of 2025 consisted primarily of employee severance benefits and other restructuring costs related to the plan approved by the Board of Directors of the Company on July 29, 2024 (the “2024 Plan”) and other restructuring actions, including the continuation of the global supply chain transformation initiatives from prior years. With the 2024 Plan, the Company seeks to improve operational performance and drive stockholder value creation. In connection with the 2024 Plan, which is expected to be substantially completed by the end of 2025, the Company anticipates a net reduction in the Company’s global workforce of approximately 2% to 4%. The proposed changes are subject to co-determination processes with employee representative groups in countries where required. Actions taken under the 2024 Plan will seek to further streamline the Company’s operations and global footprint, as well as improve alignment of the Company’s cost structure with its strategic growth objectives. As of March 31, 2025, the Company has incurred $30 million in restructuring charges under the 2024 Plan since its inception. In total, including the charges already incurred, the Company expects to incur between $35 million and $50 million in non-recurring restructuring charges under the 2024 Plan, primarily related to employee transition, severance payments, and employee benefits, which are expected to be expensed and paid in cash by the end of 2025. With the restructuring plan approved by the Board of Directors of the Company on February 14, 2023 (the “2023 Plan”), the Company sought to restructure the business through a new operating model with five global business units, optimize central functions and overall management infrastructure, and implement other efforts aimed at cost savings. The 2023 Plan’s annual cost savings target of $200 million has been substantially met, with the benefits mostly offset in the short term by additional investments in sales personnel, the Company’s new global Enterprise Resource Planning (“ERP”) system, and other transformation initiatives. As of March 31, 2025, the Company has incurred $86 million in restructuring charges under the 2023 Plan since its inception, primarily related to employee transition, severance payments, employee benefits, and facility closure costs, and $20 million in other non-recurring costs related to restructuring activities, which mostly consist of consulting, legal, and other professional service fees. Remaining restructuring charges attributable to the 2023 Plan are not expected to be material. The estimates of the charges and expenditures that the Company expects to incur in connection with the 2024 Plan, and the timing thereof, are subject to several assumptions, including local law requirements in various jurisdictions and co-determination aspects in countries where required. Actual amounts may differ materially from estimates. In addition, the Company may incur additional charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the 2024 Plan. The liabilities associated with the Company's restructuring plans are recorded in Accrued liabilities and Other noncurrent liabilities in the Consolidated Balance Sheets. Activity in the Company’s restructuring accruals at March 31, 2025 was as follows:
|  |  |  | Severance
(in millions) |  |  |  | 2023 and Prior Plans |  | 2024 Plans |  | Other Actions |  | Total
Balance at December 31, 2024 |  |  |  | $ | 13 |  |  | $ | 19 |  |  | $ | — |  |  | $ | 32 |
Provisions |  |  |  | — |  |  | 2 |  |  | 6 |  |  | 8 |
Amounts applied |  |  |  | (6) |  |  | (9) |  |  | — |  |  | (15) |
Change in estimates |  |  |  | (1) |  |  | — |  |  | — |  |  | (1) |
Balance at March 31, 2025 |  |  |  | $ | 6 |  |  | $ | 12 |  |  | $ | 6 |  |  | $ | 24 |
|  | Other Restructuring Costs
(in millions) |  | 2023 and Prior Plans |  | 2024 Plans |  | Other Actions |  | Total
Balance at December 31, 2024 |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | 1 |
Provisions |  | — |  |  | — |  |  | — |  |  | — |
Amounts applied |  | — |  |  | — |  |  | — |  |  | — |
Balance at March 31, 2025 |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | 1 |
The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows:
(in millions) |  | December 31, 2024 |  | Provisions |  | Amounts Applied |  | Change in Estimates |  | March 31, 2025
Connected Technology Solutions |  | $ | 9 |  |  | $ | 2 |  |  | $ | (7) |  |  | $ | (1) |  |  | $ | 3 |
Essential Dental Solutions |  | 11 |  |  | (2) |  |  | (3) |  |  | — |  |  | 6 |
Orthodontic and Implant Solutions |  | 9 |  |  | 1 |  |  | (2) |  |  | — |  |  | 8 |
Wellspect Healthcare |  | 3 |  |  | 1 |  |  | (1) |  |  | — |  |  | 3 |
All Other |  | 1 |  |  | 6 |  |  | (2) |  |  | — |  |  | 5 |
Total |  | $ | 33 |  |  | $ | 8 |  |  | $ | (15) |  |  | $ | (1) |  |  | $ | 25 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration